Biomarkers, type II collagen, glucosamine and chondroitin sulfate in osteoarthritis follow-up: The "Magenta osteoarthritis study"

Journal of Orthopaedics and Traumatology

Volumn 9, Issue 2, 2008, Pages 81-87

  Scarpellini, Magda ^a   Lurati, A ^a   Vignati, G ^a   Marrazza, M G ^a   Telese, F ^a   Re, K ^a   Bellistri, A ^a  

^a Magenta Hospital   (Italy)

Author keywords

Cartilage; Osteoarthritis; Type II collagen; uCTX I; uCTX II

Indexed keywords

BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CHONDROITIN SULFATE; COLLAGEN TYPE 2; GLUCOSAMINE;

ADULT; AGED; ARTICLE; BODY MASS; BONE RADIOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; FEMALE; FOLLOW UP; HAND DISEASE; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OSTEOARTHRITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; VISUAL ANALOG SCALE;

EID: 44949180632     PISSN: 15909921     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10195-008-0007-5     Document Type: Article

References (28)

1. Ihyc A, Osiecka-Iwan A, Jozwiak J, Moskalewski S (2001) The morphology and selected biological properties of articular cartilage. Ortop Traumatol Rehabil 3(2):151-162
2. Morales TI (2007) Chondrocyte moves: Clever strategies? Osteoarthritis Cartilage 15(8):861-871
3. Reijman M, Hazes JM, Bierma-Zeinstra SM, Koes BW, Christgau F, Christiansen C, Uitterlinden AG, Pols HA (2004) A new marker for osteoarthritis: Cross-sectional and longitudinal approach. Arthritis Rheum 50(8):2471-2478
4. Charni N, Juillet F, Garnero P (2005) Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 52(4):1081-1090
5. Jordan KM, Syddall HE, Garnero P, Gneyts E, Dennison EM, Sayer AA, Delmas PD, Cooper C, Arden NK (2006) Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men. Ann Rheum Dis 65(7):871-877
6. Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant H, Peterfy C, Burlet N, Ethgen D, Montague T, Dabrowski C, Reginster JY (2006) Osteoarthritis, magnetic resonance imaging, and biochemical markers: A one year prospective study. Ann Rheum Dis 65(8):1050-1054
7. Conrozier T, Ferrand F, Poole AR, Verret C, Mathieu P, Ionescu M, Vincent F, Piperno M, Spiegel A, Vignon E (2007) Differences in biomarkers of type II collagen in atrophic and hypertrophic osteoarthritis of the hip: Implications for the differing pathobiologies. Osteoarthritis Cartilage 15(4):462-467
8. Sharif M, Kirwan J, Charni N, Sandell LJ, Whittles C, Garnero P (2007) A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis-association with disease progression. Rheumatology 46(6):938-943
9. Garnero P, Charni N, Juillet F, Conrozier T, Vignon E (2006) Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis. Ann Rheum Dis 65:1639-1644
10. Mazières B, Garnero P, Guéguen A, Abbal M, Berdah L, Lesquesne M, Nguyen M, Salles J-P, Vignon E, Dougados M (2006) Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis 65:354-359
11. Meulenbelt I, Kloppenburg M, Kroon HN, Houwing-Dustermaat JJ, Garnero P, Hellio Le Graverand MP, DeGroot J, Slagboom PE (2006-2007) Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: The GARP study. Ann Rheum Dis 65:360-365 - Osteoarthritis Cartilage 15:379-385
12. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, Brown C, Cooke TD, Daniel W, Gray R, Greenwald R, Hochberg M, Howell D, Ike R, Kapila P, Kaplan D, Koopman W, Longley S, McShane DJ, Medsger T, Michel B, Murphy W, Osial T, Ramsey-Goldman R, Rothschild B, Stark K, Wolfe F (1990) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 33:1601-1610
13. Kellgren JH (1963) The epidemiology of chronic rheumatism. In: Davis FA (ed) Atlas of standard radiographs of arthritis. vol II. Blackwell Scientific Publication, Philadelphia, pp 10-1114
14. Lorenz H, Wenz W, Ivancic M, Steck E, Richter W (2005) Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint localization and histological grading. Arthritis Res Ther 7(1):R156-R165
15. Bettica P, Cline G, Hart DJ (2002) Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study. Arthritis Rheum 46(12):3178-3184
16. Sandell LJ, Ainier T (2001) Articular cartilage and changes in arthritis. An introduction: Cell biology of osteoarthritis. Arthritis Res 3:107-113
17. Lajeunesse D (2007) Does subchondral bone tissue remodeling or cell function play a role in articular cartilage loss in osteoarthritis? Osteoarthritis Cartilage 15(Suppl):C3
18. Marcelli C, Favier F, Kotzki PO, Ferrazzi V, Picot MC, Simon L (1995) The relationship between osteoarthritis of the hands, bone mineral density, and osteoporotic fractures in elderly women. Osteoporos Int 5(5):382-388
19. Zoli A, Lizzio MM, Capuano A, Massafra U, Barini A, Ferraccioli G (2006) Osteoporosis and bone metabolism in postmenopausal women with osteoarthritis of the hand. Menopause 13(3):462-466
20. Ramsbottom H, Lockwood B (2006) Nutriceutical for healthy joints. Pharmacogenomics J 277:740-746
21. Lippiello L, Woodward J, Karpman R, Hammad TA (2000) In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulphate. Clin Orthop Relat Res 381:229-240
22. Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR Jr, Oddis CV, Wolfe F, Molitot JA, Yocum DE, Schnitzre TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ (2006) Glucosamine, chondroitin sulphate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354(8):795-808
23. Pelletier JP, Martel-Pelletier J (2007) DMOAD developments: Present and future. Bull NYU Hosp Jt Dis 65(3):242-248
24. Trentham DE, Halpner AD, Trentham RA, Bagchi M, Kothari S, Preuss HG, Bagchi D (2001) Use of undenatured type II collagen in the treatment of rheumatoid arthritis. Clin Pract Altern Med 2:254-259
25. Bagchi D, Misner B, Bagchi M, Cothari SC, Downs BW, Fafard RD, Preuss HG (2002) Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: A mechanistic exploration. Int J Clin Pharmacol Res 22(3-4):101-110
26. D'Altilio M, Peal A, Alvey M, Simms C, Curtsingrer A, Gupta RC, Canerdy TD, Good JT, Magchi M, Bagchi D (2007) Therapeutic efficacy and safety of undenatured type II collagen singly or in combination with glucosamine and chondroitin in arthritic dogs. Toxicol Mech Methods 17(4):189-196
27. El-Sherrif HE, Kamal R, Moawyah O (2008) Hand osteoarthritis and bone mineral density in postmenopausal women; clinical relevance to hand function, pain and disability. Osteoarthritis Cartilage 168(1):12-17
28. Sowers M, Lachance L, Jamadar D, Hochberg MC, Hollis B, Crutchfield M, Jannausch ML (1999) The associations of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in pre-and perimenopausal women. Arthritis Rheum 42(39):483-489